Wealth Awesome
TSX open
Loading markets…
Interactive Brokers: IBKR clients beat the S&P 500 in 2025 — 19.20% average client return vs 17.9% for the index, net of commissions and charges.
ETF Comparison · Canada
FTXH
First Trust Nasdaq Pharmaceuticals ETF
vs
IBB
iShares Biotechnology ETF

A side-by-side comparison of First Trust Nasdaq Pharmaceuticals ETF (FTXH) and iShares Biotechnology ETF (IBB) to help Canadian investors make an informed decision.

FTXH
First Trust Nasdaq Pharmaceuticals ETF
Price
$42.06
YTD Return
+18.33%
AUM
$1.20B
MER
0.6%
52W High
$45.10
52W Low
$31.28
IBB
iShares Biotechnology ETF
Price
$203.72
YTD Return
+17.46%
AUM
$11.41B
MER
0.45%
52W High
$222.29
52W Low
$159.65

1-Year Performance

Normalised to 100 at the start — shows relative return over the trailing 12 months.

FTXHIBBBase = 100 (1 year ago)
-5.0%1.5%8.0%14.5%21.0%27.5%Jun 17Jul 28Sep 3Oct 13Nov 19

Head-to-Head Comparison

MetricFTXHIBB
YTD Return+18.33%✓+17.46%
1-Day Change-2.26%-0.81%✓
1-Week Change-4.73%-4.55%✓
1-Month Change-1.60%✓-3.70%
Current Price$42.06$203.72
AUM$1.20B$11.41B✓
MER (Expense Ratio)0.6%0.45%✓
Dividend Yield0.66%✓0.16%
Distribution Frequency——
Inception Date2016-09-202001-02-05
Holdings Count50236
MorningStar Rating——
CategoryHealthcare EquityHealthcare Equity
Beta0.310.60
52-Week High$45.10$222.29
52-Week Low$31.28$159.65
50-Day MA$42.18$208.95
200-Day MA$37.81$186.82

✓ marks the better value for return/yield/AUM metrics. Lower ✓ for MER.

Annualised Returns

PeriodFTXHIBB
YTD+18.33%✓+17.46%
1 Year+41.34%✓+33.04%
3 Year+23.17%+23.63%✓
5 Year+11.44%✓+7.39%
10 Year+9.63%✓+8.83%
1Y Volatility15.04%18.42%
Sharpe Ratio (3Y)1.371.03

Past performance is not a guarantee of future results.

Top 10 Holdings

FTXH Holdings
1LLYEli Lilly and Company8.73%
2ABBVAbbVie Inc7.61%
3JNJJohnson & Johnson6.83%
4PFEPfizer Inc6.77%
5MRKMerck & Company Inc6.65%
6VTRSViatris Inc4.12%
7REGNRegeneron Pharmaceuticals Inc4.24%
8GILDGilead Sciences Inc4.06%
9BIIBBiogen Inc4.05%
10ZTSZoetis Inc3.57%
IBB Holdings
1GILDGilead Sciences Inc9.21%
2AMGNAmgen Inc8.31%
3VRTXVertex Pharmaceuticals Inc8.14%
4REGNRegeneron Pharmaceuticals Inc6.75%
5MRNAModerna Inc5.80%
6ARGXargenx NV ADR3.84%
7NTRANatera Inc2.86%
8BIIBBiogen Inc2.70%
9ONCBeOne Medicines AG2.38%
10RVMDRevolution Medicines Inc2.19%

Sector Weights

SectorFTXHIBB
Basic Materials0.00%0.00%
Communication Services0.00%0.00%
Consumer Cyclicals0.00%0.00%
Consumer Defensive0.00%0.00%
Energy0.00%0.00%
Financial Services0.00%0.00%
Healthcare100.00%100.00%
Industrials0.00%0.00%
Real Estate0.00%0.00%
Technology0.00%0.00%
Utilities0.00%0.00%

About FTXH

The fund will normally invest at least 80% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.

About IBB

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

Which ETF is Right for You?

Both FTXH and IBB are listed on Canadian exchanges and accessible through most Canadian brokerages including Questrade, Wealthsimple Trade, TD Direct, and Interactive Brokers.

Based on the available data, FTXH scores higher across our tracked metrics including YTD performance, dividend yield, and AUM — though both ETFs warrant individual research before investing.

  • Consider your account type (TFSA, RRSP, non-registered) as it can affect dividend taxation.
  • Compare management expense ratios (MER) directly on each provider's website.
  • Look at average daily trading volume to assess liquidity.
  • Review the fund's underlying index and holdings to ensure the exposure matches your goals.

This is not financial advice. Always do your own research or consult a licensed financial advisor before investing.

Frequently Asked Questions

What is the difference between FTXH and IBB?

FTXH (First Trust Nasdaq Pharmaceuticals ETF) and IBB (iShares Biotechnology ETF) are both Canadian-listed ETFs. Key differences include their AUM ($1.20B vs $11.41B), dividend yield (0.66% vs 0.16%), and year-to-date performance (+18.33% vs +17.46%).

Is FTXH better than IBB?

There is no single "better" ETF — it depends on your investment goals. If you prioritise recent performance, FTXH has outperformed year-to-date. Always review the fund's prospectus and consider your tax situation.

Can I buy FTXH and IBB on Wealthsimple?

Most Canadian-listed ETFs are available on Wealthsimple Trade commission-free. Both FTXH and IBB should be accessible. Check Wealthsimple's supported tickers list to confirm availability.

Free newsletter · Every Saturday morning

The Saturday TSX Wrap

The week on the TSX, in five minutes.

  • The biggest gainers and losers, and why they moved
  • Sector and momentum moves at a glance
  • The Canadian market stories you missed

Free. One email a week. Unsubscribe any time.

← ETF ScreenerETF Guides HubFTXH ProfileIBB Profile